CapForce
OpGen, Inc., a US-based company, offers automated microbial genetics analysis and whole genome sequencing services.
Founded
2001OpGen, Inc., a US-based company, offers automated microbial genetics analysis and whole genome sequencing services.
Founded in Gaithersburg, United States, OpGen, Inc. is dedicated to advancing microbial genetics analysis. The company's core mission is to enhance the understanding and management of infectious diseases through innovative genomic solutions. OpGen provides a platform for automated microbial whole genome analysis, which includes comparative genomics, whole genome sequence assembly, and strain characterization. Their services cater to a wide range of customers across the United States, focusing on improving laboratory capabilities in microbial research and diagnostics.
OpGen has attracted notable investors and industry experts who support its mission to revolutionize microbial genomics. The company has achieved significant milestones in developing its proprietary technologies and expanding its service offerings. OpGen's impact is evident in the enhanced capabilities it provides to laboratories, enabling more precise and comprehensive microbial analysis. This contributes to better disease management and a deeper understanding of microbial genetics, positioning OpGen as a key player in the field of genomic healthcare.
Companies similar to CapForce include Pathogenetix, Genome Insight, GenomeNext and Gencove.
CapForce was founded in 2001.
CapForce's headquarters is located in Gaithersburg, MD, US.
CapForce's most recent funding round was for $7.5M (USD) in January 2023.
As of Jan 6, 2023, CapForce has raised a total of $169.6M (USD).
CapForce has 100 employees as of Feb 6, 2024.
